CTNM CONTINEUM THERAPEUTICS CLASS A
Health Care · Russell 2000
Next earnings: not announced yet
What 9 analyst firms say about CONTINEUM THERAPEUTICS CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
9 rated views · 11 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8035
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8020
Recent analyst activity · last 90 days
Our tracked history has 9 reports on CTNM from 6 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 2 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Baird lowered its target from $19.00 (set 15 Sep 2026) to $14.00 on 13 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Daniel C Moore | Hold | 13 Oct 2026 | 14.00 USD |
| Baird | Joel Beatty | Hold | 13 Oct 2026 | 14.00 USD |
| Jonestrading | Debanjana Chatterjee | Buy | 15 Oct 2026 | 30.00 USD |
| Leerink Partners | Faisal Khurshid | Buy | 13 Nov 2025 | 22.00 USD |
| Leerink Partners | Roanna Ruiz | Buy | 19 Aug 2026 | 22.00 USD |
| Morgan Stanley | Jeffrey Hung | Hold | 28 Sep 2026 | 17.00 USD |
| RBC Capital Markets | Brian Abrahams | Buy | 31 Jul 2026 | Conflicting reports · excluded |
| Stifel | Paul Matteis | — | 30 Sep 2026 | 28.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| William Blair | Myles R Minter | Buy | 31 Jul 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:34 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.